2017 Europe Biotechnology Conference, 26-27 September, Dublin, Ireland

Biotechnology Factories of the Future
Five Megatrends in Technology and Regulatory Development

Do capacity constraints hinder patient access to Biologics?

Biopharmaceutical products are facing a prosperous future. The 2017 ISPE Europe Conference on Biotechnology, will focus on:

  • Capacity constraints
  • Innovative tools in knowledge management
  • Process science
  • Technological advancements and trends to approach future challenges in the biotechnology industry

Keynote speaker Gerald Kierans, from Pfizer, will address the capacity situation of CMOs, CROs, and Analytical Laboratories, as well as the demand for key discipline expertise as the biotechnology industry expands and diversifies.

Dominic Carolan from NIBRT in Dublin will address the need for qualified work force.  How to get the right people trained and educated?

Bjoern Philipp Kloke and Martin Zindler will speak about individualised medicines in biologics.

Why attend?

  • Hear what the new megatrends are and how it will influence your operations and shape the future
  • Learn about how to ensure "capable capacities" at CMOs, CROs, and Analytical Laboratories
  • Discover professional ideas on how to develop the "Biotech Workforce of the Future"
  • Learn what biotechnology industry leaders’ thoughts are for tomorrow
  • Engage with Regulators addressing the regulatory framework for biologics
  • Explore new ways to address patient needs with new product types such as Biosimilars, Biobetters, ADCs, and ATMPs
  • Learn from the challenges in manufacturing personalised medicines
  • Network with colleagues and speakers to learn about best practice ideas and influencers


Event Sponsors

Join ISPE today and save hundreds of dollars on registration as well as enjoy other great membership benefits.

Join now!

Receive Notifications

Stay up-to-date on education sessions, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2017 Europe Biotechnology Conference.